CDO1 and colorectal cancer: Using a microarray-based approach, Brait and colleagues (33) identified CDO1 expression to be modulated in colorectal cancer cell lines by promoter methylation and following treatment with the DNA demethylating agent 5-aza-2′-deoxycytidine.